封面
市场调查报告书
商品编码
1487665

粪便管理系统市场规模- 按类型(产品[结肠造口袋、冲洗系统、神经调製设备]、配件)、患者类型(成人、儿童)、最终用途(医院、家庭护理场所、ASC) - 全球预测2024 年- 2032 年

Stool Management System Market Size - By Type (Products [Colostomy Bags, Irrigation Systems, Nerve Modulation Devices], Accessories), Patient Type (Adult, Pediatric), End-use (Hospitals, Homecare Settings, ASCs) - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在技​​术升级的推动下,特别是在更便携和用户友好的系统方面,2024 年至 2032 年间,全球粪便管理系统市场规模将以 3.8% 的复合年增长率扩大。这些创新满足了患者不断变化的需求,提供了更高的舒适度和便利性。此外,对综合护理解决方案(包括皮肤保护剂和除臭剂等配件)的需求不断增长,进一步推动了市场扩张。随着患者寻求更有效、更全面的肠道疾病和失禁治疗,市场以先进技术和更广泛的解决方案做出回应,推动其规模和成长潜力。

例如,2022 年 2 月,康乐保在新加坡推出了 SenSura(R) Mio,这是一种新型造口护理技术,提高了造口者的生活品质。该创新产品针对那些接受过造口手术的人,支持造口管理。这一发展显示人们专注于提高患者的舒适度、便利性和造口护理的有效性。它标誌着旨在提高全球造口者生活品质的创新解决方案的趋势。

粪便管理系统产业根据类型、患者类型、最终用途和地区进行细分。

到 2032 年,由于配件在提高粪便管理系统的效率和舒适度方面发挥着至关重要的作用,配件细分市场将显着增长。皮肤保护剂、造口袋、除胶剂和除臭剂等产品补充了核心系统,提供全面的护理解决方案。随着人们越来越重视患者舒适度和皮肤健康,对这些配件的需求不断增加。此外,针对各种需求和偏好定制的各种配件的可用性进一步推动了该细分市场在不断变化的粪便管理系统市场前景中的主导地位。

到 2032 年,家庭护理设置领域将获得大幅增长,这主要是由于人们越来越偏好家庭医疗保健解决方案,尤其是老年人和残疾人。在家管理粪便相关状况的便利性和舒适性,与便携式和用户友好型粪便管理系统的进步相一致,有助于该细分市场的主导地位。此外,不断上涨的医疗成本和对独立的渴望将进一步推动家庭护理环境中对粪便管理系统的需求,使其成为市场的关键参与者。

受该地区老年人口不断增长和胃肠道疾病患病率上升的推动,到 2032 年,亚太地区粪便管理系统市场将录得显着的复合年增长率。此外,中国、日本和印度等国家医疗保健基础设施的改善和医疗保健支出的增加进一步促进了市场成长。凭藉积极主动地满足医疗保健需求和庞大的消费者基础,亚太地区将成为新兴粪便管理系统产业的关键贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 对微创手术的需求不断增长
      • 材料科学的技术进步
    • 产业陷阱与挑战
      • 先进的粪便管理系统成本高昂
  • 成长潜力分析
  • 监管环境
  • 2023 年定价分析
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势
  • 缺口分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按类型,2018 - 2032

  • 主要趋势
  • 产品
    • 结肠造口袋
    • 灌溉系统
    • 神经调节装置
    • 其他产品
  • 配件

第 6 章:市场估计与预测:按病患类型,2018 年 - 2032 年

  • 主要趋势
  • 成人
  • 儿科

第 7 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 家庭护理设置
  • 医院
  • 门诊手术中心

第 8 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Coloplast A/S
  • Convatec Inc.
  • Dansac A/S
  • Hollister Incorporated
  • HR Pharmaceuticals, Inc.
  • Medtronic plc
  • Peak Medical Ltd.
  • Pelican Healthcare Limited
  • Salts Healthcare Ltd.
  • Welland Medical Limited.
简介目录
Product Code: 8511

Global Stool Management System Market size will expand at a 3.8% CAGR between 2024 and 2032, fueled by technological upgrades, particularly in more portable and user-friendly systems. These innovations cater to evolving patient needs, offering enhanced comfort and convenience. In addition, the growing demand for comprehensive care solutions, including accessories like skin protectants and odor eliminators, further propels market expansion. As patients seek more effective and holistic management of bowel disorders and incontinence, the market responds with advanced technologies and a wider range of solutions, driving its size and potential for growth.

For instance, in February 2022, Coloplast introduced SenSura(R) Mio, a new stoma care technology in Singapore, enhancing ostomates' quality of life. The innovative product targets those who have undergone ostomy surgery, supporting stoma management. This development indicates a focus on improving patient comfort, convenience, and the effectiveness of stoma care. It signifies a trend towards innovative solutions aimed at enhancing the quality of life for ostomates worldwide.

The stool management system industry is segmented based on type, patient type, end-use, and region.

The accessories segment will witness a noteworthy rise by 2032, propelled by the crucial role of accessories in enhancing the efficiency and comfort of stool management systems. Products such as skin protectants, pouches, adhesive removers, and odor eliminators complement the core systems, offering comprehensive care solutions. With a growing emphasis on patient comfort and skin health, the demand for these accessories is on the rise. Additionally, the availability of a wide range of accessories tailored to various needs and preferences further propels the segment's dominance in the evolving stool management system market outlook.

The homecare settings segment will garner substantial gains through 2032, primarily due to the growing preference for home-based healthcare solutions, especially among the elderly and individuals with disabilities. The convenience and comfort of managing stool-related conditions at home, in line with advancements in portable and user-friendly stool management systems, contribute to the segment's dominance. Moreover, rising healthcare costs and the desire for independence will further propel the demand for stool management systems in homecare settings, making them a key player in the market.

Asia Pacific stool management system market will record a remarkable CAGR by 2032, driven by the region's growing elderly population and rising prevalence of gastrointestinal disorders. Additionally, improvements in healthcare infrastructure and increasing healthcare expenditure in countries like China, Japan, and India further bolster market growth. With a proactive approach towards addressing healthcare needs and a significant consumer base, Asia Pacific will emerge as a key contributor to the burgeoning stool management system industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancements in material science
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of advanced stool management systems
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis, 2023
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Products
    • 5.2.1 Colostomy bags
    • 5.2.2 Irrigation systems
    • 5.2.3 Nerve modulation devices
    • 5.2.4 Other products
  • 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Patient Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Adult
  • 6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Homecare settings
  • 7.3 Hospitals
  • 7.4 Ambulatory surgical centers

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 B. Braun Melsungen AG
  • 9.2 Becton, Dickinson and Company
  • 9.3 Coloplast A/S
  • 9.4 Convatec Inc.
  • 9.5 Dansac A/S
  • 9.6 Hollister Incorporated
  • 9.7 HR Pharmaceuticals, Inc.
  • 9.8 Medtronic plc
  • 9.9 Peak Medical Ltd.
  • 9.10 Pelican Healthcare Limited
  • 9.11 Salts Healthcare Ltd.
  • 9.12 Welland Medical Limited.